Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined replapsed or refractory diffuse large B-cell lymphoma
Lenz, G., et al. Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined replapsed or refractory diffuse large B-cell lymphoma. Leukemia 2020 (34) 2184-2197. https://doi.org/10.1038/s41375-020-0743-y
- Categories
- Peer Reviewed Publications